Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 47
  • Journal CiteScore: 16.17
  • Journal Impact Factor: 2.63
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +441518081309
20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

A FADOI Survey on Heart Failure Management in Campanian Internal Medicine Wards

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Gallucci F, Coppola MG, Ciarambino T, Iorio V, Marrone E, Mastrobuoni C, Romano C and Morella P

UOC Medicina Interna 3, AORN A. Cardarelli, Napoli, Italy
UOC Medicina Interna, Ospedale del Mare, Napoli, Italy
UOC Medicina Interna, Ospedale Anastasia Guerriero, Marcianise (CE), Italy
UOC Medicina Interna, AORN S.G. Moscati, Avellino, Italy
Gruppo Ricerca Cardiovascolare, FADOI Campania, Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

Background and aims: Despite the diagnostic and therapeutic advances obtained, heart failure (HF) is still a difficult to manage syndrome. Materials and methods: In October 2020, we sent a questionnaire (Q) about HF management to Campanian FADOI members; 70 of them answered. Results: The patient (pt) with HF is hospitalized in Int Med (78.6%), Card (1.4%), it depends (20%). Pt with HF/total admissions<25% (22.9%), 25-50% (70%), >50% (7.1%). NYHA: II (20%), III (72.9%), IV (7.1%). Optimal therapy>75% (1.4%), 51-75% (18.6%), 25-50% (52.9%), <25% (27.1%). Echocardiogram during the hospital stay: HR (4.3%), HR and ward (W) (41.4%), W (51.4%), rarely (2.9%) Thoracic Echography: No (22.9%), HR (12.9%), HR+W (7.1%), W (17.1%), rarely (40%). QoL Q: No (67.1%), Rarely (25.7%), Often (7.1%). Length of stay: 3-7 days (37.1%), 8-15 days (60%), 16- 30 days (2.9%). Follow-up: Hospital Ambulatory (A) (32.9%), WA (21.4%), territorial A (4.3%), General practitioner (20%), Cardiologist (C)(21.4%). HF A in hospital: Yes (65.7%), No (34.3%). Managed by: C (56.5%), Internist (10.9%), both (32.6%). Territorial paths upon discharge: Yes (40%), No (60%). Hygiene and dietary recommendations in the discharge letter: Always (27.1%), sometimes (68.6%), Never (4.3%). Comorbidities influence the therapy: No (1.4%), Very little (8.6%), Little (36.7%), Very much (54.3%). Availability of "non-pharmacological" HF treatment: Yes (74.3%), at other facilities (12.9%), No (12.9%). Experience with the most recent drugs for HF: No (5.7%), little (30%), only in monitored in A (15.7%), during hospitalization (48.6%). Conclusions: The survey shows a heterogeneous situation: more work needs to optimize the management of HF. References 1. Gallucci F, Fontanella A, Ronga I, Uomo G, FASHION Study Group (2017) Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study. IJM 11: 184- 190. 2. Gallucci F (2021) Modelli a confronto nei percorsi gestionali dello scompenso cardiaco: l’esperienza campana. Quaderni - Italian Journal of Medicine 9: e17.